EE700 The Budget Impact of Venetoclax Plus Obinutuzumab for First-Line Chronic Lymphocytic Leukemia in Saudi Arabia
Dec 1, 2024, 00:00
10.1016/j.jval.2024.10.980
https://www.valueinhealthjournal.com/article/S1098-3015(24)03843-9/fulltext
Title :
EE700 The Budget Impact of Venetoclax Plus Obinutuzumab for First-Line Chronic Lymphocytic Leukemia in Saudi Arabia
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(24)03843-9&doi=10.1016/j.jval.2024.10.980
First page :
Section Title :
Open access? :
No
Section Order :
10472